San-Miguel JF. Consolidation therapy in myeloma: a consolidated approach? Blood. 2012;120(1):2–3.

On page 3 of the 5 July 2012 issue, in the last paragraph of the Inside Blood commentary, the word “impossible” should have read “possible.” The sentence should have read: “Overall, this article highlights the benefit of VTD consolidation after double ASCT with emphasis in the high-risk population and although additional ongoing trials need to confirm these results, it is possible that ‘consolidation treatment’ will become a ‘consolidated’ part of the therapeutic scheme of younger patients.” The error has been corrected in the online version, which now differs from the print version.